Might Confounding Factors Have an Effect on Suboptimal Dosing of Fluconazole in Critically Ill Patients?
作者信息
Kara Emre, Bayraktar Ekincioglu Aygin, Metan Gokhan
机构信息
Hacettepe University Faculty of Pharmacy, Department of Clinical Pharmacy, Ankara, Turkey
Hacettepe University Faculty of Pharmacy, Department of Clinical Pharmacy, Ankara, Turkey.
出版信息
Antimicrob Agents Chemother. 2021 Jan 20;65(2). doi: 10.1128/AAC.02118-20.
Abstract
摘要
相似文献
1
Might Confounding Factors Have an Effect on Suboptimal Dosing of Fluconazole in Critically Ill Patients?混杂因素是否会对重症患者氟康唑给药不足产生影响？
Antimicrob Agents Chemother. 2021 Jan 20;65(2). doi: 10.1128/AAC.02118-20.
2
Reply to Kara et al., "Might Confounding Factors Have an Effect on Suboptimal Dosing of Fluconazole in Critically Ill Patients?".对卡拉等人《混杂因素是否会对重症患者氟康唑剂量不足产生影响？》一文的回复
Antimicrob Agents Chemother. 2021 Jan 20;65(2). doi: 10.1128/AAC.02147-20.
3
Pharmacokinetic evaluation of fluconazole in critically ill patients.氟康唑在危重症患者中的药代动力学评价。
Expert Opin Drug Metab Toxicol. 2011 Nov;7(11):1431-40. doi: 10.1517/17425255.2011.615309. Epub 2011 Sep 2.
4
Fluconazole dosing predictions in critically-ill patients receiving prolonged intermittent renal replacement therapy: a Monte Carlo simulation approach.接受长期间歇性肾脏替代治疗的重症患者的氟康唑给药剂量预测：一种蒙特卡洛模拟方法。
Clin Nephrol. 2016 Jul;86(7):43-50. doi: 10.5414/CN108824.
5
Effect of Obesity on the Population Pharmacokinetics of Fluconazole in Critically Ill Patients.肥胖对危重症患者氟康唑群体药代动力学的影响。
Antimicrob Agents Chemother. 2016 Oct 21;60(11):6550-6557. doi: 10.1128/AAC.01088-16. Print 2016 Nov.
6
Fluconazole pharmacokinetics in a morbidly obese, critically ill patient receiving continuous venovenous hemofiltration.接受持续静静脉血液滤过的病态肥胖重症患者的氟康唑药代动力学
Pharmacotherapy. 2014 Sep;34(9):e162-8. doi: 10.1002/phar.1470. Epub 2014 Jul 30.
7
Inadequate proof of adverse outcome due to the use of fluconazole in critically ill patients.在重症患者中使用氟康唑导致不良后果的证据不足。
Arch Surg. 2000 Sep;135(9):1114.
8
Suboptimal exposure to fluconazole in critically ill patients: Pharmacokinetic analysis and determinants.危重症患者氟康唑暴露不足：药代动力学分析与影响因素。
Infect Dis Now. 2023 Mar;53(2):104630. doi: 10.1016/j.idnow.2022.10.002. Epub 2022 Oct 31.
9
Fluconazole prophylaxis for critically ill patients at high risk for Candida infection.对念珠菌感染高危的重症患者进行氟康唑预防治疗。
Clin Infect Dis. 2005 Dec 1;41(11):1690-1. doi: 10.1086/498349.
10
Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials.用于预防非中性粒细胞减少的重症患者和外科手术患者真菌感染的抗真菌药物：随机临床试验的系统评价和荟萃分析
J Antimicrob Chemother. 2006 Apr;57(4):628-38. doi: 10.1093/jac/dki491. Epub 2006 Feb 3.
本文引用的文献
1
Suboptimal Dosing of Fluconazole in Critically Ill Patients: Time To Rethink Dosing.危重症患者氟康唑剂量不足：是时候重新考虑剂量了。
Antimicrob Agents Chemother. 2020 Sep 21;64(10). doi: 10.1128/AAC.00984-20.
2
The epidemiology of polypharmacy in older adults: register-based prospective cohort study.老年人多重用药的流行病学：基于登记的前瞻性队列研究。
Clin Epidemiol. 2018 Mar 12;10:289-298. doi: 10.2147/CLEP.S153458. eCollection 2018.
3
A study of harmful drug-drug interactions due to polypharmacy in hospitalized patients in Goa Medical College.果阿医学院住院患者因多种药物联合使用导致的有害药物相互作用研究。
Perspect Clin Res. 2017 Oct-Dec;8(4):180-186. doi: 10.4103/picr.PICR_132_16.
4
Effect of Obesity on the Population Pharmacokinetics of Fluconazole in Critically Ill Patients.肥胖对危重症患者氟康唑群体药代动力学的影响。
Antimicrob Agents Chemother. 2016 Oct 21;60(11):6550-6557. doi: 10.1128/AAC.01088-16. Print 2016 Nov.
5
The Effect on mortality of fluconazole or echinocandins treatment in candidemia in internal medicine wards [corrected].内科病房念珠菌血症中氟康唑或棘白菌素治疗对死亡率的影响[已修正]
PLoS One. 2015 May 4;10(5):e0125149. doi: 10.1371/journal.pone.0125149. eCollection 2015.
6
Pharmacokinetic variability and exposures of fluconazole, anidulafungin, and caspofungin in intensive care unit patients: Data from multinational Defining Antibiotic Levels in Intensive care unit (DALI) patients Study.重症监护病房患者中氟康唑、阿尼芬净和卡泊芬净的药代动力学变异性及暴露量：来自多国重症监护病房抗生素水平界定（DALI）患者研究的数据。
Crit Care. 2015 Feb 4;19(1):33. doi: 10.1186/s13054-015-0758-3.
7
Estimation of renal function in the intensive care unit: the covert concepts brought to light.重症监护病房肾功能评估：隐性概念浮出水面。
J Intensive Care. 2014 May 7;2(1):31. doi: 10.1186/2052-0492-2-31. eCollection 2014.
8
Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome.阿尼芬净与氟康唑治疗白念珠菌引起的念珠菌血症和其他形式的侵袭性念珠菌病的比较：与改善结局相关的多变量分析因素。
BMC Infect Dis. 2011 Sep 30;11:261. doi: 10.1186/1471-2334-11-261.
9
Frequency of potential azole drug-drug interactions and consequences of potential fluconazole drug interactions.潜在唑类药物相互作用的频率及氟康唑潜在药物相互作用的后果。
Pharmacoepidemiol Drug Saf. 2005 Nov;14(11):755-67. doi: 10.1002/pds.1073.
Zotero 插件